Concepedia

Mengwen Feng

MF

Statistics

Publications

10

Citations

224

H-Index

10

Active since

2018

Affiliations

Nanjing Medical University(Current)

Jiangsu Province Hospital

Tongren Hospital

Shanghai Jiao Tong University

Nanjing Drum Tower Hospital

Mengwen Feng is an author at Nanjing Medical University specializing in life sciences, molecular biology, and pharmacology.

ORCID

Publications per year

2018–2024

10

Publications

10

Attenuation of Na/K-ATPase/Src/ROS amplification signal pathway with pNaktide ameliorates myocardial ischemia-reperfusion injury

Hua Li, Anwen Yin, Zijie Cheng et al. · International Journal of Biological Macromolecules · 2018 · 36 citations

, , +11

Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p

Xuejun Wang, Zijie Cheng, Jia Xu et al. · Life Sciences · 2020 · 35 citations

, , +14

Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway

Li Zhang, Mengwen Feng, Xuejun Wang et al. · International Journal of Molecular Medicine · 2021 · 30 citations · Full text

, , +17

The long non-coding RNA uc.4 influences cell differentiation through the TGF-beta signaling pathway

Zijie Cheng, Qijun Zhang, Anwen Yin et al. · Experimental & Molecular Medicine · 2018 · 28 citations · Full text

, , +17

ELA-11 protects the heart against oxidative stress injury induced apoptosis through ERK/MAPK and PI3K/AKT signaling pathways

Xuejun Wang, Li Zhang, Mengwen Feng et al. · Frontiers in Pharmacology · 2022 · 23 citations · Full text

, , +17

1–5 of 10